Valentijn Schweitzer (@schweitzer_va) header
Valentijn Schweitzer (@schweitzer_va) profile picture

Medical doctor | Epidemiologist | Resident Clinical Microbiology @UMCUtrecht | Member of @TAESCMID

Utrecht, The Netherlands
Joined July 2018
Photo by Valentijn Schweitzer (@schweitzer_va)Photo by Valentijn Schweitzer (@schweitzer_va)Photo by Valentijn Schweitzer (@schweitzer_va)Photo by Valentijn Schweitzer (@schweitzer_va)Photo by Valentijn Schweitzer (@schweitzer_va)Photo by Valentijn Schweitzer (@schweitzer_va)Photo by Valentijn Schweitzer (@schweitzer_va)Photo by Valentijn Schweitzer (@schweitzer_va)Photo by Valentijn Schweitzer (@schweitzer_va)Photo by Valentijn Schweitzer (@schweitzer_va)
Valentijn Schweitzer retweeted
The AMR Action Subcommittee and Study Group for Artificial intelligence and Digitalisation (ESGAID) recently published a perspective on the implications of using AI in the fight against #AMR. Check it out: ow.ly/Bbwm50YeZTF
1
10
11
1,127
Valentijn Schweitzer retweeted
Check out this article by two of our AMR Action Subcommittee members exploring the importance of building connections between science and policy as we address the global concern of #AMR. ow.ly/Fjpp50Uctsl #WAAW2024 #escmidAMR #AntimicrobialResistance
7
12
1,368
Valentijn Schweitzer retweeted
Annual meeting of the PRImAVeRA consortium that investigates potential effects of vaccines & monoclonal antibodies on infections caused by antibiotic resistant bacteria. @IHIEurope
🏥El @HUVMacarena acoge una reunión internacional sobre eficacia de vacunas y anticuerpos monoclonales en la resistencia a #antimicrobianos @EuropeVaccine @PROAmacarena hospitalmacarena.es/historic…
2
9
1,094
🔥 Topic in Infectious Diseases! High-quality clinical data are needed! 🆕️⚡️⚡️Favourable effect of clavulanic acid on the minimum inhibitory concentrations of cefixime and ceftibuten in ESBL-producing Escherichia coli and Klebsiella pneumoniae #idxposts sciencedirect.com/science/ar…
3
22
1
65
19,417
Valentijn Schweitzer retweeted
Improving disseminated histoplasmosis diagnosis in HIV/AIDS patients in Suriname: The role of a urine lateral flow assay #AZP @IenI_UMCUtrecht @diakhuis @amsterdamumc @_Westerdijk_ @InFocusLatAm @ISHAM_Mycology @eurconfmedmycol @efisg_escmid doi.org/10.1371/journal.pntd…
7
1
15
1,666
Valentijn Schweitzer retweeted
Most patients with sepsis don't need anti-anaerobic antibiotics. But most get them anyway. Why not, what's the harm? I worry the harm is considerable. Our new study in @JAMAInternalMed: using a 15-month pip-tazo shortage to answer this question. 1/n jamanetwork.com/journals/jam…
30
244
52
660
269,159
Valentijn Schweitzer retweeted
Do clinical trials of antimicrobial agents give clinicians the information they need in order to change guidelines and revise their prescribing patterns? A thread on a new way to analyze clinical trial results
3
39
2
91
16,325
Valentijn Schweitzer retweeted
🍄 Great to see that fungi are getting more recognition -we certainly are seeing them more and more in medical practice . I am very honoured to be here -excited to discuss with Dutch colleagues on their clinical experience and practice. @ferryhagen @_Westerdijk_ @schweitzer_va
The king visited @_Westerdijk_ on November 7th with interest and enthusiasm. Yes, fungi become more and more important.
1
2
10
1,340
Valentijn Schweitzer retweeted
Have you seen a carbapenemase-producing Proteus (CPP) isolate in your microbiology lab? Probably yes, but likely without noticing. A thread on our latest publication @CMIJournal @UniOldenburg #IDtwitter #microrounds clinicalmicrobiologyandinfec… 1/x
1
3
8
988
Valentijn Schweitzer retweeted
Wondering how beta-lactam resistance occurs in Staphylococcus aureus (e.g. MRSA)? A short 🧵 on the two most common mechanisms of beta-lactam resistance in S. aureus ...
8
119
9
386
77,316
ß-D-glucans in CSF for non-crypto 🍄 infection. Sensitivity 72% in proven/probable IFIs. Specificity 82% in well defined control population ⚠️false positive w/ bacterial infections, strokes, drug toxicity ⬇️ @Jeanne_big academic.oup.com/cid/advance…
1
15
35
2,298
Wow!! 🔥A practice changing RCT🔥 26 US and Canada N: 887 Pip-tazo Vs Cefoxitin preop in OPEN Pancreatoduodenectomy (Whipple) TZP as perioperative prophylaxis reduced postoperative SSI, pancreatic fistula,and multiple downstream sequelae of SSI Cefoxitin🤔 jamanetwork.com/journals/jam…
11
51
6
189
99,260
Valentijn Schweitzer retweeted
Where can (relatively) young people get their research funding? From Challenges for early career scientists in 2023 by Valentijn SCHWEITZER, Netherlands #ECCMID2023
1
1
7
1,045
Join @TAEscmid organised events today at #ECCMID2023 In particular the first on-site Research Bites session, where CM/ID trainees from around the world will present cutting edge research.
4
4
590
Valentijn Schweitzer retweeted
SAFO Trial in #ECCMID2023 Main findings: Shorted duration of bacteremia But similar mortality As per predicted by @DrToddLee QnA: How many were complicated vs. unc. The majority were unc. Sec outcome of persistent bacteremia was defined as bacteremia > 72H
3
55
3
127
26,157
🔥PROSTASHORT​ RCT🔥 Shorter course of 7d of antibiotic therapy with ofloxacin was inferior to a longer course of 14d in treatment of FEBRILE UTI in MEN & resulted in unfavorable outcomes in a higher percentage of participants Exception #shorterisbetter academic.oup.com/cid/advance…
7
37
8
140
118,612
Valentijn Schweitzer retweeted
Make sure to register for the upcoming @ESCMID course on „AMS in travel-/migration associated infections“ in March at Homburg/Saar, Germany 🦠🩺🩹🧫☀️🌎 Exciting program with fantastic speakers! 💪🏻💪🏼💪🏽🤓 #IDtwitter escmid.org/fileadmin/src/med…
12
2
24
3,538
Valentijn Schweitzer retweeted
Curious to learn more about antimicrobial stewardship (AMS) in the context of migration- and travel-associated infections? Join us for the ESCMID postgraduate course at Homburg/Saar, Germany from March 17-19th 2023 Details here: kurzelinks.de/5rs1
1
16
28